Market Research Logo

Poland Pharmaceuticals and Healthcare Report Q2 2016

Poland Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The impending shift to a tax-based healthcare system will provide enticing revenue earning opportunities for multinational pharmaceutical firms operating in Poland, while the country's increasing pensionable population will drive demand in high-value medicines for the treatment of chronic diseases, such as cancer and cardiovascular diseases. However, the government's ambitious spending initiatives risk overstretching finances in the future, forcing it to moderate a number of its plans for the sector.

Headline Expenditure Projections

Pharmaceuticals: PLN33.39bn (USD8.86bn) in 2015 to PLN34.76bn (USD8.61bn) in 2016; +4.1% in local currency terms and -2.8% in US dollar terms. Forecast revised downwards from last quarter.

Healthcare: PLN115.74bn (USD30.70bn) in 2015 to PLN121.83bn (USD30.18bn) in 2016; +5.3% in local currency terms and -1.7% in US dollar terms. Forecast revised downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Poland 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020)
Prescription Drug Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020)
Generic Drug Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Poland 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2014-2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Poland Risk/Reward Index
Rewards
Risks
Regulatory Review
Advertising Regulations
Other Regulatory Developments
Intellectual Property Regime
Pricing And Reimbursement
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Civilian Outpatient Facilities, 2002-2009
Table: Healthcare Resources (Poland 2010-2015)
Table: Healthcare Personnel (Poland 2010-2015)
Table: Healthcare Activity (Poland 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Table: Number Of Pharmacies In Poland, 2004-2009
Company Profile
Bioton
Polpharma
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Poland 1990-2025)
Table: Key Population Ratios (Poland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Poland 1990-2025)
Table: Population By Age Group (Poland 1990-2025)
Table: Population By Age Group % (Poland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report